Viking Global Investors
Private EquityInvestment management firm focused on long/short equity strategies in global markets, founded by Andreas Halvorsen.
Profile
Capital
Portfolio
3 companiesCandid Therapeutics is a clinical-stage biotechnology company developing novel T-cell engager antibodies to treat autoimmune and inflammatory diseases. The company's platform redirects T-cells to selectively eliminate autoreactive B-cells, with clinical programs spanning five autoimmune indications. Founded by Ken Song after his $4.1B sale of RayzeBio to Bristol Myers Squibb.
Synthetic biology company that builds an automated platform for programming cells, enabling customers across pharmaceuticals, agriculture, and industrial chemicals to harness the power of biology.
Apeel Sciences develops plant-derived, edible coatings that extend the shelf life of fresh produce by slowing water loss and oxidation. Founded with a Bill and Melinda Gates Foundation grant, the company's FDA-approved coatings are made from lipids found in fruit peels, enabling longer freshness without refrigeration. Used by major retailers including Costco, Kroger, and Walmart.
Investment data is compiled from multiple independent sources including company announcements, press coverage, and regulatory filings. While we strive for accuracy, amounts and dates may reflect reported figures at time of announcement.